Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference [Yahoo! Finance]
MEDIFAST INC (MED)
Last medifast inc earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.medifastnow.com
Company Research
Source: Yahoo! Finance
converting the world's most meaningful medications into liquid oral suspensions for delivery in proprietary digitally connected devices, announced that Michael Demurjian, CEO & Chairman, will participate in a panel discussion at the American Urological Association (AUA) Innovation Nexus Conference in Las Vegas, Nevada, taking place on April 25, 2025. Mr. Demurjian will participate in the panel discussion titled "The Good, the Bad and the Ugly: How to Approach Investors" scheduled for 8:05 - 8:50 a.m. PT on Friday, April 25. As CEO of Aspargo Labs – the company behind HEZKUE®, a first-of-its-kind liquid oral sildenafil suspension already on the market in multiple countries – Mr. Demurjian brings a unique perspective on commercializing innovation in urology and successfully raising capital for groundbreaking products. The panel will be moderated by Andrew Cleeland, BS, CEO of Fogarty Innovation, and will feature fellow panelists Ryan Drant, Founder and Director of Questa Capital Manag
Show less
Read more
Impact Snapshot
Event Time:
MED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MED alerts
High impacting MEDIFAST INC news events
Weekly update
A roundup of the hottest topics
MED
News
- OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and WellbeingBusiness Wire
- 5 Insightful Analyst Questions From Medifast's Q3 Earnings Call [Yahoo! Finance]Yahoo! Finance
- Medifast: Between Obsolescence And Optionality [Seeking Alpha]Seeking Alpha
- MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges [Yahoo! Finance]Yahoo! Finance
- Medifast Announces Third Quarter 2025 Financial ResultsBusiness Wire
MED
Earnings
- 11/3/25 - Miss
MED
Sec Filings
- 11/13/25 - Form SCHEDULE
- 11/3/25 - Form 10-Q
- 11/3/25 - Form 8-K
- MED's page on the SEC website